Cardiol Therapeutics (CRDL) Q4 2024 Earnings
CRDL·Reported March 31, 2025·Before market open
Diluted EPS came in at $-0.07 (+30.0% YoY), beat the $-0.08 consensus by $0.01.
Diluted EPS
$-0.07beat by $0.01
Consensus: $-0.08
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q4 2024 Earnings FAQ
Common questions about Cardiol Therapeutics's Q4 2024 earnings report.
Cardiol Therapeutics (CRDL) reported Q4 2024 earnings on March 31, 2025 before market open.
Cardiol Therapeutics reported diluted EPS of $-0.07 for Q4 2024.
EPS beat the consensus estimate of $-0.08 by $0.01.
Compared to the same quarter a year prior, diluted EPS grew 30.0% from $-0.10.